News | Women's Health | May 11, 2017

3-D Mammography Changing the Face of Cancer Screening and Treatment

Global market research gives insight to the competitive mammography landscape

mammography exam

Photo courtesy of Hologic

Breast cancer is one of the leading causes of death of women worldwide. In Canada, according to the Canadian Cancer Society, one in every nine women is expected to develop breast cancer in her lifetime, and one in thirty will die from it. Though breast cancer rates were high relatively high in the 1990s, they decreased in the 2000s—and continue to remain much lower than they were in the 80s and 90s—thanks to the increased use of mammography. Mammography can detect early breast cancer in women experiencing no symptoms and is an essential tool and lifesaving measure. According to Infiniti Research, the global market for mammography devices and equipment will grow at a rate of more than 9 percent until 2020.

Infiniti Research has recently completed a market assessment on the mammography device market for a leading global manufacturer and supplier of diagnostic products, medical imaging systems, and surgical products. The purpose of this study was to help the client assess and analyze the competitive landscape for mammography devices.

 

Market Trends

Though 2-D mammography has long been an effective and affordable industry standard, 3-D mammography is becoming more popular. While 2-D mammography captures two static images of the breast, 3-D mammography takes multiple images of the breast, allowing for a more comprehensive and accurate picture, and reducing the risk of missing abnormalities due to image overlap. However, the benefits of 3-D mammography over 2-D have yet to be fully proven, and 3-D mammography is more expensive for uninsured patients. Another popular method involves combining 2-D and 3-D mammography, though this is currently very new. Some studies have suggested that 3-D mammography puts the patient at a higher risk for cancer from radiation, though this has not yet been confirmed.

 

Market Opportunities

Because the use of 3-D and combination 2-D and 3-D mammography is still relatively new and the risks associated with it are still largely unknown or unconfirmed, market intelligence is critical for vendors looking to enter this market. To keep their patients safe and establish themselves as reliable, vendors need to be up-to-date on market trends and developments, medical advancements and challenges, and how breast cancer incidence and treatment differs around the world.

In their latest assessment of the global mammography device market, Infiniti’s market intelligence analysts helped their client, a leading global manufacturer and supplier of diagnostic products, to gain an in-depth understanding of how the competitive landscape for mammography devices and equipment differed across the world, with special focus on target countries including the US, Germany, China, Great Britain, Australia, and France. Infiniti’s analysts researched and monitored the latest developments in the market through journals and whitepapers, and also conducted extensive interviews with stakeholders such as channel partners, business executives, and suppliers in order to develop a holistic overview of the market scenario.

 

You can view the complete study here: https://www.infinitiresearch.com/casestudy/competitive-intelligence-assessment-mammography-devices

Related Content

Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
The ASPIRE Cristalle FFDM system with DBT combines Fujifilm’s state-of-the-art hexagonal close pattern (HCP) detector design, advanced image processing and image acquisition workflow
News | Women's Health | August 01, 2017
Fujifilm Medical Systems U.S.A., Inc. announced that The Mammography Center of Monterey, an ACR-accredited breast...
Sponsored Content | Videos | Breast Imaging | July 28, 2017
Nancy Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy, explains how
Radiotherapy Prior to Surgery Reduces Secondary Tumor Risk in Early-Stage Breast Cancer Patients
News | Radiation Therapy | July 24, 2017
Moffitt Cancer Center researchers launched a first-of-its-kind study comparing the long-term benefits of radiation...
X-ray performed on a GE Optima 646 DR system. The FDA has updated its radiology reporting forms on its website.
News | Business | July 24, 2017
July 24, 2017 — The U.S.
Kubtec Launches New Website For Digital Imaging and Irradiation Products
News | Digital Radiography (DR) | July 20, 2017
Kubtec announced the launch a new website focused on the applications of digital X-ray imaging and irradiation for...
Volpara Solutions to Showcase Volpara Enterprise DDP Software at AHRA 2017
News | Mammography | July 11, 2017
Volpara Solutions Inc. will showcase its new Volpara Enterprise DDP software at the Association for Medical Imaging...
Fujifilm Showcases Digital Radiography, Mammography Innovations at AHRA 2017
News | Digital Radiography (DR) | July 06, 2017
Fujifilm Medical Systems U.S.A. Inc. will present its comprehensive portfolio of digital radiography (DR) and...
Feature | Breast Density | July 05, 2017 | By Nancy M. Cappello, Ph.D.
Two decades of research on the masking risk of dense breast tissue by mammography screening is indisputable. As the...
Solis Mammography Ranks No. 19 in Dallas Business Journal’s Middle Market 50
News | Mammography | June 30, 2017
June 30, 2017 — Solis Mammography was named the 19th fastest-growing, middle-market company in North Texas by the
Overlay Init